Premium
Production of the Alzheimer's β‐amyloid peptide by C6 glioma cells
Author(s) -
Morato Esperanza,
Mayor Federico
Publication year - 1993
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/0014-5793(93)80819-g
Subject(s) - p3 peptide , peptide , amyloid precursor protein , immunoprecipitation , biochemistry of alzheimer's disease , amyloid (mycology) , antibody , extracellular , alzheimer's disease , biochemistry , glioma , chemistry , microbiology and biotechnology , biology , immunology , pathology , cancer research , medicine , disease , inorganic chemistry
The β‐amyloid peptide (Aß) is a 4 kDa proteolytic fragment derived from the β‐amyloid precursor protein (βAPP) which is deposited as amyloid fibrils in the brains of patients with Alzheimer's disease. βAPP processing was investigated in C6 glioma cells using several affinity‐purified anti‐peptide antibodies raised against different domains of the protein. Both direct immunoblot analysis of C6 glioma conditioned medium and metabolic labeling of cells followed by immunoprecipitation of extracellular medium with specific antibodies revealed that these glial cells normally produce and release a soluble 4 kDa peptide which co‐migrates with synthetic Aß (1–40) and is specifically recognized by antibodies raised against N‐ or C‐terminal domains of the β‐amyloid peptide. Our results further suggest that glial cells may prove a major source of β‐amyloid production in the nervous tissue.